Koers Bafna Pharmaceuticals Limited Bombay S.E.
Aandelen
BAFNAPH
INE878I01022
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
91,08 INR | +1,95% | +1,92% | -2,92% |
Omzet 2022 | 851 mln. 10,2 mln. 9,36 mln. | Omzet 2023 | 1,15 mld. 13,82 mln. 12,69 mln. | Marktkapitalisatie | 1,94 mld. 23,24 mln. 21,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 51 mln. 611K 561K | Nettowinst (verlies) 2023 | 113 mln. 1,35 mln. 1,24 mln. | EV/omzet 2022 | 3,65 x |
Nettoschuld 2022 | 109 mln. 1,3 mln. 1,2 mln. | Nettoschuld 2023 | 151 mln. 1,81 mln. 1,66 mln. | EV/omzet 2023 | 1,81 x |
K/w-verhouding 2022 |
58,4
x | K/w-verhouding 2023 |
17,1
x | Werknemers | 588 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 10,36% |
1 dag | +1,95% | ||
1 week | +1,92% | ||
Lopende maand | +22,95% | ||
1 maand | +17,96% | ||
3 maanden | +3,87% | ||
6 maanden | -9,47% | ||
Lopend jaar | -2,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 01-01-81 | |
M. Sridhar
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 01-01-81 | |
Krishna Yeachuri
BRD | Director/Board Member | 63 | 26-06-23 |
Director/Board Member | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
12-07-24 | 91,08 | +1,95% | 7 480 |
11-07-24 | 89,34 | +0,04% | 501 |
10-07-24 | 89,3 | +4,38% | 1 766 |
09-07-24 | 85,55 | -1,19% | 484 |
08-07-24 | 86,58 | -3,11% | 825 |
uitgestelde koers Bombay S.E., 12 juli 2024 om 12:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+25,24% | 45,45 mld. | |
+34,85% | 24,63 mld. | |
+30,49% | 16,9 mld. | |
+21,32% | 14,57 mld. | |
+70,51% | 14,02 mld. | |
-0,05% | 6,79 mld. | |
-10,06% | 6,61 mld. | |
+15,26% | 5,79 mld. | |
-8,87% | 5,73 mld. |
- Beurs
- Aandelen
- Koers BAFNAPH
- Koers BAFNAPH